Does ERDAFITINIB Cause Disease progression? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Disease progression have been filed in association with ERDAFITINIB (BALVERSA). This represents 3.7% of all adverse event reports for ERDAFITINIB.
41
Reports of Disease progression with ERDAFITINIB
3.7%
of all ERDAFITINIB reports
8
Deaths
14
Hospitalizations
How Dangerous Is Disease progression From ERDAFITINIB?
Of the 41 reports, 8 (19.5%) resulted in death, 14 (34.1%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERDAFITINIB. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does ERDAFITINIB Cause?
Death (255)
Off label use (86)
Diarrhoea (75)
Stomatitis (58)
Fatigue (45)
Onycholysis (44)
Dry mouth (41)
Nail disorder (40)
Hyperphosphataemia (39)
Dry eye (38)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ERDAFITINIB Alternatives Have Lower Disease progression Risk?
ERDAFITINIB vs ERENUMAB
ERDAFITINIB vs ERENUMAB-AOOE
ERDAFITINIB vs ERENUMAB\ERENUMAB-AOOE
ERDAFITINIB vs ERGOCALCIFEROL
ERDAFITINIB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL